Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation
Open Access
- 13 March 2026
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (5) , 2840-2862
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness (NEIP30EY01730)
- Sight Research UK (SAC054)
- Wellcome Trust (224586/Z/21/Z)
- Wellcome Trust (222064/Z/20/Z)
- Medical Research Council (MR/X502856/1)
- National Eye Institute
- National Institute for Health and Care Research
- Moorfields Eye Hospital NHS Foundation Trust
- Wellcome
- UCL Institute of Ophthalmology, University College London
- National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
- Foundation Fighting Blindness
This publication has 129 references indexed in Scilit:
- Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphateCell, 2023
- Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic NeuropathyAmerican Journal of Ophthalmology, 2022
- Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile EffectsDrugs, 2020
- Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 GeneJAMA Ophthalmology, 2019
- The PI3K Pathway in Human DiseaseCell, 2017
- Macrophage physiology in the eyePflügers Archiv - European Journal of Physiology, 2017
- The role of MHC class Ib-restricted T cells during infectionImmunogenetics, 2016
- PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease ModelsChemistry & Biology, 2013
- Therapeutic Dosing of Fingolimod (FTY720) Prevents Cell Infiltration, Rapidly Suppresses Ocular Inflammation, and Maintains the Blood-Ocular BarrierThe American Journal of Pathology, 2012
- Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory DiseaseArchives of Ophthalmology (1950), 2008